Cargando…

Darunavir-Resistant HIV-1 Protease Constructs Uphold a Conformational Selection Hypothesis for Drug Resistance

Multidrug resistance continues to be a barrier to the effectiveness of highly active antiretroviral therapy in the treatment of human immunodeficiency virus 1 (HIV-1) infection. Darunavir (DRV) is a highly potent protease inhibitor (PI) that is oftentimes effective when drug resistance has emerged a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Zhanglong, Tran, Trang T., Pham, Linh, Hu, Lingna, Bentz, Kyle, Savin, Daniel A., Fanucci, Gail E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695139/ https://www.ncbi.nlm.nih.gov/pubmed/33171603 http://dx.doi.org/10.3390/v12111275

Ejemplares similares

Unique Flap Conformation in an HIV-1 Protease with High-Level Darunavir Resistance
por: Nakashima, Masaaki, et al.
Publicado: (2016)

Structures of Darunavir-Resistant HIV-1 Protease Mutant Reveal Atypical Binding of Darunavir to Wide Open Flaps
por: Zhang, Ying, et al.
Publicado: (2014)

Management of Antiretroviral Therapy with Boosted Protease Inhibitors—Darunavir/Ritonavir or Darunavir/Cobicistat
por: Marin, Ruxandra-Cristina, et al.
Publicado: (2021)

Evaluation of novel protease inhibitors against darunavir‐resistant variants of HIV type 1
por: Inoue, Mari, et al.
Publicado: (2016)

Effects of drug-resistant mutations on the dynamic properties of HIV-1 protease and inhibition by Amprenavir and Darunavir
por: Yu, Yuqi, et al.
Publicado: (2015)

Combating HIV resistance – focus on darunavir
por: Tremblay, Cécile L
Publicado: (2008)

Resistance mutations in protease gene at baseline are not related to virological failure in patients treated with darunavir/ritonavir monotherapy
por: Gutierrez-Liarte, Angela, et al.
Publicado: (2014)

Protease mutations emerging on darunavir in protease inhibitor-naïve and experienced patients in the UK
por: El Bouzidi, Kate, et al.
Publicado: (2014)

Science in the fight to uphold the rights of children
por: Caplan, Arthur L., et al.
Publicado: (2018)

Darunavir resistance spectrum in darunavir-na#239;ve patients harboring virological failure to antiretroviral therapy
por: Marcelin, AG, et al.
Publicado: (2010)

Upholding Scientific Duty Amidst Poisonous Disinformation
por: Barbosa, Daniel A. N., et al.
Publicado: (2020)

The structural, dynamic, and thermodynamic basis of darunavir resistance of a heavily mutated HIV-1 protease using molecular dynamics simulation
por: Shabanpour, Yaser, et al.
Publicado: (2022)

Prevalence of Darunavir Resistance in the United States from 2010 to 2017
por: Brown, Kimberley, et al.
Publicado: (2018)

Consent Codes: Upholding Standard Data Use Conditions
por: Dyke, Stephanie O. M., et al.
Publicado: (2016)

Diuretics: A possible keystone in upholding cognitive health
por: DeLoach, Tyler, et al.
Publicado: (2018)

US Supreme Court upholds abortion rights, for now
por: Jaffe, Susan
Publicado: (2020)

Acquired HIV-1 Protease Conformational Flexibility Associated with Lopinavir Failure May Shape the Outcome of Darunavir Therapy after Antiretroviral Therapy Switch
por: Eche, Simeon, et al.
Publicado: (2021)

2482. Clinical Outcomes of Once-Daily Darunavir in Treatment-Experienced Patients with Darunavir Resistance Associated Mutations Through 48 Weeks of Treatment
por: Rolle, Charlotte-Paige M, et al.
Publicado: (2019)

Upholding veterinary services as a pillar of one health in Myanmar
por: Chan, Olivia Sinn Kay, et al.
Publicado: (2021)

The L33F darunavir resistance mutation acts as a molecular anchor reducing the flexibility of the HIV-1 protease 30s and 80s loops
por: Kuiper, Benjamin D., et al.
Publicado: (2015)

The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms
por: Gao, Xiaobo, et al.
Publicado: (2019)

The implications of autonomy: Viewed in the light of efforts to uphold patients dignity and integrity
por: Delmar, Charlotte, et al.
Publicado: (2011)

Undernutrition, obesity and governance: a unified framework for upholding the right to food
por: Bump, Jesse B
Publicado: (2018)

Public health nursing: Leading in communities to uphold dignity and further progress
por: Sullivan-Marx, Eileen
Publicado: (2020)

Darunavir in experienced patients
por: Sterrantino, G, et al.
Publicado: (2010)

Improved kidney function in patients who switch their protease inhibitor from atazanavir or lopinavir to darunavir
por: Jose, Sophie, et al.
Publicado: (2017)

Darunavir–cobicistat–emtricitabine–tenofovir alafenamide: safety and efficacy of a protease inhibitor in the modern era
por: Squillace, Nicola, et al.
Publicado: (2018)

Cobicistat/darunavir/cobicistat/darunavir/emtricitabine/tenofovir-alafenamide/darunavir/ritonavir: Various toxicities and off-label use: 9 case reports
Publicado: (2020)

Virologic outcomes of switching to boosted darunavir plus dolutegravir with respect to history of drug resistance
por: Wolf, Eva, et al.
Publicado: (2021)

Mission impossible: upholding successfully a charge of infanticide in the Albanian legal practice
por: Myftari, Kreshnik, et al.
Publicado: (2014)

Upholding morality and honesty in global scientific research during the coronavirus disease pandemic
por: Lyu, Peng, et al.
Publicado: (2020)

Invest in health and uphold rights to “build back better” after COVID-19
por: Clark, Helen, et al.
Publicado: (2020)

Upholding justice through music: protesting betrayal in Oromo song, Wal Agarraa()
por: Jebessa, Kassaye Gutema, et al.
Publicado: (2022)

Upholding Human Rights in the Wake of COVID-19: Time to Strengthen Pharmaceutical Accountability
por: Turkie, Rosalind
Publicado: (2022)

Five ways ‘health scholars’ are complicit in upholding health inequities, and how to stop
por: Shahram, Sana Z.
Publicado: (2023)

Publisher Correction: The HIV protease inhibitor darunavir prevents kidney injury via HIV-independent mechanisms
por: Gao, Xiaobo, et al.
Publicado: (2020)

Long term effect of switching to darunavir/ritonavir in HIV infected patients previously on protease inhibitor therapy
por: Ucciferri, Claudio, et al.
Publicado: (2016)

Low offspring survival in mountain pine beetle infesting the resistant Great Basin bristlecone pine supports the preference-performance hypothesis
por: Eidson, Erika L., et al.
Publicado: (2018)

Darunavir/cobicistat showing similar effectiveness as darunavir/ritonavir monotherapy despite lower trough concentrations
por: Gutierrez‐Valencia, Alicia, et al.
Publicado: (2018)

Mechanism of Darunavir (DRV)’s High Genetic Barrier to HIV-1 Resistance: A Key V32I Substitution in Protease Rarely Occurs, but Once It Occurs, It Predisposes HIV-1 To Develop DRV Resistance
por: Aoki, Manabu, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mk4uuvc5kknn3ttv4cg2v722pc